tradingkey.logo

SI-BONE Inc

SIBN

17.900USD

+0.510+2.93%
Close 08/04, 16:00ETQuotes delayed by 15 min
760.38MMarket Cap
LossP/E TTM

SI-BONE Inc

17.900

+0.510+2.93%
More Details of SI-BONE Inc Company
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Company Info
Ticker SymbolSIBN
Company nameSI-BONE Inc
IPO dateOct 17, 2018
CEOMs. Laura A. Francis
Number of employees349
Security typeOrdinary Share
Fiscal year-endOct 17
Address471 El Camino Real, Suite 101
CitySANTA CLARA
Stock exchangeMoscow Interbank Currency Exchange (MICEX)
CountryUnited States of America
Postal code95050
Phone14082070700
Websitehttps://si-bone.com/
Ticker SymbolSIBN
IPO dateOct 17, 2018
CEOMs. Laura A. Francis
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
168.86K
+5.42%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.89K
+4.75%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
28.77K
-12.68%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
28.02K
+44.83%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
19.16K
+82.75%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
11.73K
+284.15%
Mr. Daniel W. (Dan) Wolf
Mr. Daniel W. (Dan) Wolf
Independent Director
Independent Director
2.86K
-83.33%
Mr. Michael A. Pisetsky
Mr. Michael A. Pisetsky
Secretary, Chief Business & Legal Affairs Officer
Secretary, Chief Business & Legal Affairs Officer
--
--
Mr. Anthony J. Recupero, Ph.D.
Mr. Anthony J. Recupero, Ph.D.
President - Commercial Operations
President - Commercial Operations
--
--
Ms. Laura A. Francis
Ms. Laura A. Francis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
168.86K
+5.42%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.89K
+4.75%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
28.77K
-12.68%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
28.02K
+44.83%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
19.16K
+82.75%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
11.73K
+284.15%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
44.84M
94.81%
International
2.45M
5.19%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
OrbiMed Advisors, LLC
8.08%
BlackRock Institutional Trust Company, N.A.
7.57%
Brown Advisory
7.48%
American Century Investment Management, Inc.
6.20%
Champlain Investment Partners, LLC
6.09%
Other
64.58%
Shareholders
Shareholders
Proportion
OrbiMed Advisors, LLC
8.08%
BlackRock Institutional Trust Company, N.A.
7.57%
Brown Advisory
7.48%
American Century Investment Management, Inc.
6.20%
Champlain Investment Partners, LLC
6.09%
Other
64.58%
Shareholder Types
Shareholders
Proportion
Investment Advisor
44.35%
Investment Advisor/Hedge Fund
35.40%
Private Equity
8.08%
Hedge Fund
6.16%
Individual Investor
3.09%
Research Firm
2.70%
Bank and Trust
0.32%
Pension Fund
0.16%
Family Office
0.10%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
373
42.88M
100.63%
-3.55M
2025Q1
387
43.81M
102.83%
-3.10M
2024Q4
376
42.78M
100.80%
-4.52M
2024Q3
370
42.61M
102.18%
-5.88M
2024Q2
364
42.74M
103.69%
-5.64M
2024Q1
363
42.76M
104.26%
-3.79M
2023Q4
363
41.07M
101.66%
-4.86M
2023Q3
356
41.24M
102.85%
-4.82M
2023Q2
355
40.07M
113.82%
-3.95M
2023Q1
322
35.92M
102.64%
-8.94M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
OrbiMed Advisors, LLC
3.44M
8.08%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.23M
7.57%
-26.87K
-0.83%
Mar 31, 2025
Brown Advisory
3.19M
7.48%
-453.05K
-12.44%
Mar 31, 2025
American Century Investment Management, Inc.
2.64M
6.2%
+264.25K
+11.11%
Mar 31, 2025
Champlain Investment Partners, LLC
2.60M
6.09%
-125.09K
-4.60%
Mar 31, 2025
The Vanguard Group, Inc.
2.44M
5.72%
+35.35K
+1.47%
Mar 31, 2025
Silvercrest Asset Management Group LLC
1.62M
3.81%
-330.15K
-16.90%
Mar 31, 2025
First Light Asset Management, LLC
1.61M
3.78%
+475.43K
+41.81%
Mar 31, 2025
Granahan Investment Management, LLC
1.43M
3.36%
-201.87K
-12.35%
Mar 31, 2025
Paradigm Capital Management, Inc.
1.28M
2.99%
-110.58K
-7.98%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
SPDR S&P Health Care Equipment ETF
0.82%
Hypatia Women CEO ETF
0.58%
Invesco NASDAQ Future Gen 200 ETF
0.45%
iShares Micro-Cap ETF
0.16%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.14%
iShares U.S. Medical Devices ETF
0.08%
First Trust Active Factor Small Cap ETF
0.05%
iShares Russell 2000 Growth ETF
0.05%
Proshares Ultra Russell 2000
0.03%
Global X Russell 2000 ETF
0.03%
View more
SPDR S&P Health Care Equipment ETF
Proportion0.82%
Hypatia Women CEO ETF
Proportion0.58%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.45%
iShares Micro-Cap ETF
Proportion0.16%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.14%
iShares U.S. Medical Devices ETF
Proportion0.08%
First Trust Active Factor Small Cap ETF
Proportion0.05%
iShares Russell 2000 Growth ETF
Proportion0.05%
Proshares Ultra Russell 2000
Proportion0.03%
Global X Russell 2000 ETF
Proportion0.03%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI